$1.15 Billion is the total value of Eversept Partners, LP's 70 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 45.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | Buy | INVESCO QQQ TRput | $208,917,142 | +176.1% | 781,700 | +189.5% | 18.11% | +236.6% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $96,316,303 | +4.5% | 637,139 | +0.7% | 8.35% | +27.4% |
| New | GSK PLCsponsored ad | $87,268,411 | – | 2,939,070 | +100.0% | 7.56% | – | |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $78,574,987 | +10.7% | 1,269,591 | +42.7% | 6.81% | +35.0% |
| NTRA | Buy | NATERA INC | $62,469,880 | +270.6% | 1,425,602 | +199.7% | 5.41% | +351.9% |
| New | GSK PLCcall | $61,617,591 | – | 2,093,700 | +100.0% | 5.34% | – | |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $53,439,220 | -27.0% | 255,226 | -17.9% | 4.63% | -11.0% |
| DHR | Sell | DANAHER CORPORATION | $42,023,962 | -7.8% | 162,546 | -9.5% | 3.64% | +12.4% |
| SNY | Buy | SANOFIsponsored adr | $37,869,251 | -13.9% | 996,035 | +13.3% | 3.28% | +4.9% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $32,787,885 | -3.3% | 4,062,935 | -9.9% | 2.84% | +17.8% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $29,110,759 | +52.2% | 1,211,434 | +21.8% | 2.52% | +85.5% |
| NVST | Sell | ENVISTA HOLDINGS CORPORATION | $20,768,763 | -18.2% | 633,001 | -4.0% | 1.80% | -0.3% |
| ILMN | Buy | ILLUMINA INC | $20,414,912 | +214.0% | 107,002 | +203.4% | 1.77% | +282.9% |
| CYH | Buy | COMMUNITY HEALTH SYS INC NEW | $19,009,449 | -37.1% | 8,841,604 | +9.7% | 1.65% | -23.3% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $17,607,317 | +18.2% | 626,372 | +13.4% | 1.53% | +44.1% |
| BIIB | Sell | BIOGEN INC | $16,058,448 | -22.4% | 60,144 | -40.7% | 1.39% | -5.3% |
| ANTM | Sell | ELEVANCE HEALTH INC | $15,008,090 | -27.3% | 33,040 | -22.8% | 1.30% | -11.4% |
| CNC | Sell | CENTENE CORP DEL | $14,885,675 | -24.7% | 191,308 | -18.1% | 1.29% | -8.2% |
| LNTH | Buy | LANTHEUS HLDGS INC | $14,550,785 | +22.4% | 206,893 | +14.9% | 1.26% | +49.2% |
| BIIB | New | BIOGEN INCput | $13,350,000 | – | 50,000 | +100.0% | 1.16% | – |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $13,039,391 | -34.1% | 11,962,744 | -10.0% | 1.13% | -19.7% |
| ABMD | Sell | ABIOMED INC | $13,012,610 | -24.1% | 52,970 | -23.6% | 1.13% | -7.5% |
| MCRB | New | SERES THERAPEUTICS INC | $12,427,997 | – | 1,935,825 | +100.0% | 1.08% | – |
| HUM | Buy | HUMANA INC | $11,941,029 | +128.0% | 24,572 | +120.0% | 1.04% | +178.2% |
| BIIB | New | BIOGEN INCcall | $9,905,700 | – | 37,100 | +100.0% | 0.86% | – |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $9,811,717 | +90.3% | 478,387 | +7.4% | 0.85% | +131.6% |
| AMRX | Sell | AMNEAL PHARMACEUTICALS INC | $9,475,440 | -45.8% | 4,690,812 | -14.6% | 0.82% | -33.9% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $9,371,993 | -33.9% | 259,612 | -44.3% | 0.81% | -19.4% |
| GH | Sell | GUARDANT HEALTH INC | $9,230,822 | -43.7% | 171,481 | -57.8% | 0.80% | -31.3% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $8,927,074 | +179.4% | 201,833 | +133.8% | 0.77% | +241.0% |
| XBI | Sell | SPDR SER TRs&p biotech | $7,932,000 | -70.0% | 100,000 | -71.9% | 0.69% | -63.5% |
| LQDA | Sell | LIQUIDIA CORPORATION | $7,623,850 | -16.7% | 1,401,443 | -33.3% | 0.66% | +1.5% |
| XBI | Sell | SPDR SER TRcall | $7,138,800 | -63.0% | 90,000 | -65.4% | 0.62% | -54.9% |
| TARO | Buy | TARO PHARMACEUTICAL INDS LTD | $6,697,022 | -16.0% | 223,383 | +1.4% | 0.58% | +2.3% |
| GOSS | Buy | GOSSAMER BIO INC | $6,570,203 | +67.6% | 548,431 | +17.1% | 0.57% | +103.9% |
| PLRX | New | PLIANT THERAPEUTICS INC | $6,143,812 | – | 294,103 | +100.0% | 0.53% | – |
| MRUS | Sell | MERUS N V | $5,541,760 | -15.0% | 276,673 | -3.9% | 0.48% | +3.7% |
| MRK | MERCK & CO INCcall | $4,194,044 | -5.5% | 48,700 | 0.0% | 0.36% | +15.2% | |
| MRVI | Sell | MARAVAI LIFESCIENCES HLDGS I | $4,084,800 | -66.2% | 160,000 | -62.4% | 0.35% | -58.8% |
| AFMD | Buy | AFFIMED N V | $3,889,278 | +24.2% | 1,887,999 | +67.0% | 0.34% | +51.1% |
| AERI | New | AERIE PHARMACEUTICALS INC | $3,877,653 | – | 256,289 | +100.0% | 0.34% | – |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $3,568,521 | -12.7% | 1,505,705 | +4.9% | 0.31% | +6.2% |
| VERA | New | VERA THERAPEUTICS INCcl a | $3,327,109 | – | 156,129 | +100.0% | 0.29% | – |
| FATE | Sell | FATE THERAPEUTICS INC | $3,172,315 | -82.4% | 141,558 | -80.5% | 0.28% | -78.5% |
| PNT | New | POINT BIOPHARMA GLOBAL INC | $3,169,702 | – | 410,052 | +100.0% | 0.28% | – |
| A | Buy | AGILENT TECHNOLOGIES INC | $2,615,878 | +8.7% | 21,521 | +6.2% | 0.23% | +32.7% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDcall | $2,202,303 | +215.2% | 272,900 | +193.8% | 0.19% | +282.0% |
| MASS | Sell | 908 DEVICES INC | $2,151,134 | -77.8% | 130,768 | -72.2% | 0.19% | -73.0% |
| AMN | New | AMN HEALTHCARE SVCS INCput | $2,013,240 | – | 19,000 | +100.0% | 0.17% | – |
| ICLR | Buy | ICON PLC | $1,876,761 | +55.0% | 10,212 | +82.8% | 0.16% | +89.5% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $1,710,390 | -0.8% | 9,125 | +6.2% | 0.15% | +20.3% |
| XOMA | New | XOMA CORP DEL | $1,583,280 | – | 88,402 | +100.0% | 0.14% | – |
| IQV | Buy | IQVIA HLDGS INC | $1,502,919 | +15.0% | 8,297 | +37.7% | 0.13% | +39.8% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $1,481,391 | +18.1% | 7,233 | +35.1% | 0.13% | +43.8% |
| AVTR | Sell | AVANTOR INC | $1,459,259 | -95.8% | 74,452 | -93.4% | 0.13% | -94.9% |
| Buy | AADI BIOSCIENCE INC | $1,440,101 | +15.9% | 101,918 | +1.1% | 0.12% | +42.0% | |
| PKI | Buy | PERKINELMER INC | $1,315,207 | -10.2% | 10,930 | +6.2% | 0.11% | +9.6% |
| ARGX | Sell | ARGENX SEsponsored adr | $1,236,381 | -93.4% | 3,502 | -92.9% | 0.11% | -91.9% |
| MIST | Sell | MILESTONE PHARMACEUTICALS IN | $1,165,531 | +28.8% | 126,826 | -13.8% | 0.10% | +57.8% |
| RGEN | Sell | REPLIGEN CORP | $681,268 | -26.3% | 3,641 | -36.0% | 0.06% | -10.6% |
| CYH | Buy | COMMUNITY HEALTH SYS INC NEWcall | $672,735 | -10.3% | 312,900 | +56.4% | 0.06% | +9.4% |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS Icall | $612,720 | – | 24,000 | +100.0% | 0.05% | – |
| HSKA | Sell | HESKA CORP | $506,284 | -31.1% | 6,943 | -10.7% | 0.04% | -15.4% |
| ACIU | AC IMMUNE SA | $393,701 | -12.5% | 124,589 | 0.0% | 0.03% | +6.2% | |
| CABA | New | CABALETTA BIO INC | $364,359 | – | 560,466 | +100.0% | 0.03% | – |
| CSU | Sell | SONIDA SENIOR LIVING INC | $191,486 | -40.0% | 11,791 | -22.5% | 0.02% | -26.1% |
| New | THIRD HARMONIC BIO INCco | $189,700 | – | 10,000 | +100.0% | 0.02% | – | |
| ELDN | Buy | ELEDON PHARMACEUTICALS INC | $186,971 | +29.7% | 67,743 | +14.7% | 0.02% | +60.0% |
| GLYC | GLYCOMIMETICS INC | $55,489 | -7.7% | 100,579 | 0.0% | 0.01% | +25.0% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $46,135 | -27.5% | 31,172 | 0.0% | 0.00% | -20.0% | |
| SWAV | Exit | SHOCKWAVE MED INC | $0 | – | -3,300 | -100.0% | -0.04% | – |
| MASI | Exit | MASIMO CORP | $0 | – | -5,984 | -100.0% | -0.06% | – |
| ZNTL | Exit | ZENTALIS PHARMACEUTICALS INC | $0 | – | -38,342 | -100.0% | -0.08% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -14,468 | -100.0% | -0.08% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEWput | $0 | – | -60,600 | -100.0% | -0.12% | – |
| ARKK | Exit | ARK ETF TRput | $0 | – | -90,000 | -100.0% | -0.26% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -182,717 | -100.0% | -0.26% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -478,245 | -100.0% | -0.36% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEWcall | $0 | – | -191,600 | -100.0% | -0.37% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -502,587 | -100.0% | -0.37% | – |
| HQY | Exit | HEALTHEQUITY INC | $0 | – | -127,043 | -100.0% | -0.55% | – |
| IWM | Exit | ISHARES TRput | $0 | – | -50,000 | -100.0% | -0.60% | – |
| QGEN | Exit | QIAGEN NV | $0 | – | -189,907 | -100.0% | -0.64% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -78,987 | -100.0% | -0.82% | – |
| Exit | R1 RCM INCco | $0 | – | -590,819 | -100.0% | -0.88% | – | |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -256,268 | -100.0% | -1.08% | – |
| AZN | Exit | ASTRAZENECA PLCcall | $0 | – | -300,300 | -100.0% | -1.41% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -1,020,329 | -100.0% | -4.79% | – |
| GSK | Exit | GSK PLCcall | $0 | – | -1,553,700 | -100.0% | -4.81% | – |
| GSK | Exit | GSK PLCsponsored adr | $0 | – | -1,594,121 | -100.0% | -4.97% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -465,000 | -100.0% | -12.47% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.